Accelerated transcranial direct current stimulation Provides Rapid Relief for Bodily Distress Disorder: Case Series
A recent clinical breakthrough reveals that accelerated transcranial direct current stimulation (aTDCS) provides rapid, substantial relief for treatment-resistant body distress disorder (BDD). By employing multiple daily sessions, this intensive approach condenses standard month-long treatments into just 10 days, significantly reducing both pain intensity and somatic symptoms.
These findings are recently published in the Indian Journal of Psychological Medicine in 2026 by Jithin Thekkelkuthiyathottil Joseph and a multidisciplinary team of colleagues.
Implementing accelerated transcranial direct current stimulation (aTDCS) addresses the significant healthcare burden of chronic, treatment-resistant bodily distress disorder (BDD). By condensing treatment from six weeks to 10 days or less, this protocol offers a practical, cost-effective alternative to traditional month-long clinical interventions. This shift significantly enhances patient compliance and expands accessibility to advanced neuromodulation therapies.
In the case series, five patients (mean age 46) with treatment-resistant body distress disorder (BDD) received intensive neuromodulation via accelerated transcranial direct current stimulation (aTDCS). The protocol involved 20-minute sessions targeted at the motor or prefrontal cortex, delivered 2–5 times daily over an average of nine days. Post-treatment, 80% of patients achieved a clinical response, with mean Visual Analog Scale (VAS) scores falling from 9.0 to 3.8 alongside significant improvements in Clinical Global Impression–Severity (CGI-S).
From a physiological perspective, the stimulation appears to normalize dysfunctional connectivity within the brain’s descending pain modulatory network by targeting key motor regions. This process likely triggers metaplasticity, where the rapid repetition of sessions amplifies neural changes and potentially engages the body's natural opioid systems to suppress chronic pain signals. These mechanistic insights suggest that increasing session density is key to overcoming the treatment resistance typically seen in BDD.
For medical practitioners, these results highlight a safe and cost-effective method to improve patient care while significantly reducing the logistical barriers associated with long-term neuromodulation. The success of the case series provides a strong foundation for future large-scale research aimed at integrating accelerated stimulation into standard clinical practice. Future studies with control groups will be essential to establish standardized guidelines for using this tool in various treatment-resistant somatic conditions.
Reference
Joseph JT, Vishwanath R, Jammigumpula A, Purohith AN, Shenoy S, and Praharaj SK. Accelerated Transcranial Direct Current Stimulation as an Adjunctive Treatment for Rapid Symptom Relief in Bodily Distress Disorder: A Case Series. Indian J Psychol Med. 2026.
